The prevalence of multiple sclerosis in 3 US communities.
BACKGROUND
We estimated the prevalence of multiple sclerosis (MS) in 3 large geographic areas in the southern, middle, and northern United States.


METHODS
The primary data source was medical records from office visits to private neurologists' practices or to neurology departments in tertiary care facilities during a 3-year period. Additional data sources included patient advocacy groups, nursing homes, and general practitioners.


RESULTS
Three-year US age-adjusted prevalence estimates for the study areas varied substantially. The prevalence was lowest (47.2 per 100,000 population) in the Texas study area (33 degrees 30' north latitude), intermediate (86.3 per 100,000 population) in the Missouri study area (39 degrees 07' north latitude), and highest (109.5 per 100,000 population) in the Ohio study area (41 degrees 24' north latitude). The geographic differences remained strong after age-adjustment to the world standard population. The inverse association between UV light exposure and MS prevalence estimates was consistent with this observed latitude gradient. In all 3 areas, MS prevalence was highest among women, people aged 40 to 59 years, and non-Hispanics.


CONCLUSIONS
These results provide necessary prevalence estimates for community cluster investigations and establish baseline estimates for future studies to evaluate temporal trends in disease prevalence.
Noonan
Curtis W
CW
Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Williamson
Dhelia M
DM
Henry
Judy P
JP
Indian
Robert
R
Lynch
Sharon G
SG
Neuberger
John S
JS
Schiffer
Randolph
R
Trottier
Janine
J
Wagner
Laurie
L
Marrie
Ruth Ann
RA
D000328:Adult; D017677:Age Distribution; D000368:Aged; D005260:Female; D006801:Humans; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000453:epidemiology*; D015995:Prevalence; D044469:Racial Groups; D014481:United States / Q000453:epidemiology